20.9 C
New York
Monday, May 25, 2026

Biogen pushing tau drug forward despite Alzheimer’s study failure

Dive Brief:• Biogen on Thursday touted “unprecedented and compelling” results from a Phase 2 study in early Alzheimer’s disease even though the trial …

This post was originally published on this site

Subscribe
Notify of
0 Comments
Inline Feedbacks
View all comments

Stay Connected

148,957FansLike
396,312FollowersFollow
2,680SubscribersSubscribe

Latest Articles

0
Would love your thoughts, please comment.x
()
x